Cover ImageSALE
Market Research Report

Global Syphilis Testing Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 345508
Published Content info 112 Pages
Immediate Delivery Available
Price
Back to Top
Global Syphilis Testing Market 2018-2022
Published: January 24, 2018 Content info: 112 Pages
Description

About Syphilis Testing

Syphilis is a sexually transmitted disease or infection (STD or STI) caused by the bacteria Treponema pallidum.

Technavio's analysts forecast the global syphilis testing market to grow at a CAGR of 2.12% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global syphilis testing market for 2018-2022. To calculate the market size, the report considers the revenue generated from the retail sales ofkits, reagents, and instruments used in syphilis testing.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Syphilis Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Beckman Coulter
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Siemens Healthcare

Market driver

  • Increase in prevalence of syphilis
  • For a full, detailed list, view our report

Market challenge

  • Lack of trained professionals
  • For a full, detailed list, view our report

Market trend

  • increase in premarital screening
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR20292

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

  • Segmentation by technology
  • Comparison by technology
  • Global syphilis testing market by conventional testing
  • Global syphilis testing market by POC testing
  • Market opportunity by technology

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Syphilis testing market in Americas
  • Syphilis testing market in EMEA
  • Syphilis testing market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increase in premarital screening
  • Rapidly increasing demand for POC testing
  • Increasing importance of promotional activities
  • Rising rates of syphilis among men

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Beckman Coulter
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Siemens Healthcare
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global STD testing market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Market sizing 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global syphilis testing market 2017-2022 ($ millions)
  • Exhibit 09: Global syphilis testing market: Year-over-year (YoY) growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Market condition: Five forces 2022
  • Exhibit 19: Global syphilis testing market by technology 2017-2022 (%)
  • Exhibit 20: Comparison by technology
  • Exhibit 21: Global syphilis testing market by conventional testing 2017-2022 ($ millions)
  • Exhibit 22: Global syphilis testing market by conventional testing: YoY growth 2018-2022 (%)
  • Exhibit 23: Recommended tests for syphilis
  • Exhibit 24: Global syphilis testing market by POC testing 2017-2022 ($ millions)
  • Exhibit 25: Global syphilis testing market by POC testing: YoY growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by technology
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global syphilis testing market by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Syphilis testing market in Americas 2017-2022 ($ millions)
  • Exhibit 31: Syphilis testing market in Americas: YoY growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: Syphilis testing market in EMEA 2017-2022 ($ millions)
  • Exhibit 34: Syphilis testing market in EMEA: YoY growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: Syphilis testing market in APAC 2017-2022 ($ millions)
  • Exhibit 37: Syphilis testing market in APAC: YoY growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Vendor overview
  • Exhibit 46: Abbott: Business segments
  • Exhibit 47: Abbott: Organizational developments
  • Exhibit 48: Abbott: Geographic focus
  • Exhibit 49: Abbott: Segment focus
  • Exhibit 50: Abbott: Key offerings
  • Exhibit 51: Vendor overview
  • Exhibit 52: Beckman Coulter: Business segments
  • Exhibit 53: Beckman Coulter: Organizational developments
  • Exhibit 54: Beckman Coulter: Geographic focus
  • Exhibit 55: Beckman Coulter: Segment focus
  • Exhibit 56: Beckman Coulter: Key offerings
  • Exhibit 57: Vendor overview
  • Exhibit 58: Bio-Rad laboratories: Business segments
  • Exhibit 59: Bio-Rad Laboratories: Organizational developments
  • Exhibit 60: Bio-Rad Laboratories: Geographic focus
  • Exhibit 61: Bio-Rad Laboratories: Segment focus
  • Exhibit 62: Bio-Rad laboratories: Key offerings
  • Exhibit 63: Vendor overview
  • Exhibit 64: F. Hoffmann La Roche: Business segments
  • Exhibit 65: F. Hoffmann La Roche: Organizational developments
  • Exhibit 66: F. Hoffmann La Roche: Geographic focus
  • Exhibit 67: F. Hoffmann La Roche: Segment focus
  • Exhibit 68: F. Hoffmann La Roche: Key offerings
  • Exhibit 69: Vendor overview
  • Exhibit 70: Siemens Healthcare: Business segments
  • Exhibit 71: Siemens Healthcare: Organizational developments
  • Exhibit 72: Siemens Healthcare: Geographic focus
  • Exhibit 73: Siemens Healthcare: Segment focus
  • Exhibit 74: Siemens Healthcare: Key offerings
Back to Top